Growth charts, not adult cutoffs, set the thresholds in NU675's Unit 7 brief for a composite boy four years into risperidone, with metformin named if drift continues. Searches like "nu 675 unit 7 assignment example", "nu675 unit 7 sample" and "nu675 unit 7 example" land here.
What a finished NU675 Unit 7 metabolic monitoring brief looks like
A two-page brief built around one table, plus a half page of sources. The table's rows are BMI percentile and z-score on CDC growth charts, waist-to-height ratio, blood pressure percentile for age, sex and height, fasting glucose with A1c, fasting lipids, ALT, and prolactin-related signs such as breast enlargement, with a prolactin level if signs appear. Columns give his current value, how often it is checked, the level that would prompt action, and the action itself. Current values are bracketed: BMI at the [96th] percentile, waist-to-height [0.58], triglycerides [168] mg/dL, A1c [5.8] percent, ALT [52]. Above the table, a short narrative records the four-year trajectory and the acanthosis his pediatrician noted. Sources include the Canadian CAMESA guideline (Pringsheim et al., 2011) and the metformin trial by Anagnostou and colleagues (2016).
How a NU675 Unit 7 example is structured
The brief is written for year four of treatment, not the first month, so it starts from what has already happened rather than from a baseline. The narrative paragraph charts his BMI percentile at each annual visit, which shows the drift began in the first year and never reversed. Thresholds are pediatric throughout, percentiles and z-scores in place of adult cutoffs, and the brief explains why an adult waist number would mislead for a growing boy. Each action is graded: a lifestyle and family nutrition program first, metformin discussed if BMI z-score keeps rising after [six months], and a review of whether a lower dose or a switch to aripiprazole could hold his behavioral gains at lower metabolic cost. The brief states that his parents value the behavioral response highly, and it frames monitoring as the way to protect that response.
Year four, not month one
Monitoring guides mostly describe the first weeks of treatment. This brief begins from a trajectory already four years long and asks what the next measurements must catch, which changes both the intervals chosen and the thresholds that matter most.
Growth charts as the ruler
BMI percentile and z-score, blood pressure percentile and waist-to-height ratio replace adult cutoffs. A boy in a growth spurt can gain weight appropriately, the brief observes, so change is judged against the curve rather than against a fixed number.
Liver and skin in the table
An ALT of [52] and acanthosis on his neck point toward insulin resistance and possible fatty liver. The brief adds both to routine monitoring and routes the liver question to his pediatrician rather than interpreting it alone.
Metformin, with its evidence
The 2016 trial in young people with autism taking antipsychotics found metformin reduced BMI z-score compared with placebo, with gastrointestinal effects common. The brief names it as a discussion to have, conditional on the lifestyle step, and brackets any regimen.
The behavioral gain protected
His family's view that risperidone restored home life is recorded as a real benefit. Every threshold in the brief is framed as a way of keeping that gain affordable, not as a countdown to stopping the drug.
Where marks go in NU675 Unit 7
Pediatric thresholds are where this brief is most often marked down: applying adult waist or blood pressure cutoffs to a thirteen-year-old misreads every value. A table of measures and intervals with no action column cannot guide anyone, and graders treat it as unfinished. A brief written as though treatment were starting today ignores four years of trajectory the case supplies. Risperidone raises prolactin, and a brief silent on breast changes in a boy has skipped a known effect of this particular drug. The metformin trial should be cited with its population and side effects. Casting the family's wish to continue as resistance, instead of a value the monitoring serves, reads poorly. Intervals left unbracketed, a missing source for the schedule and no named clinician for each abnormal result draw brief notes.
Get a NU675 Unit 7 example written to your instructions
Give the agent, how many years the patient has taken it and whatever values your NU675 Unit 7 case lists; duration shapes a long-term brief as much as the drug does. Add the rubric, and a free first custom brief follows within 24-48h, with age-appropriate thresholds, an action beside every measure and the trajectory read first.
NU675 Unit 7 questions, answered
How does metabolic monitoring differ for children and adolescents?
Thresholds come from growth charts rather than adult cutoffs, because a growing child's weight and blood pressure are judged against age and sex norms. Young people also tend to gain weight faster on antipsychotics than adults. Say which pediatric references you use, report percentiles or z-scores, and explain how you separate expected growth from drug-related gain.
Should the brief recommend switching to a lower-risk antipsychotic?
It can raise the option, with its trade-offs. A switch may lower metabolic risk but could cost behavioral gains that took years to achieve, so the family's view matters. Present it as one action among several, tied to a threshold, and leave the decision to the prescriber and family, with the reasoning written out.
What if the case gives only some of the monitoring values?
List every measure the brief requires, report the values supplied, and mark the missing ones as needed at the next visit, with a reason for each. Do not invent numbers. A brief that identifies gaps in past monitoring can be stronger than one with a complete table, because it shows the author checked what had actually been done.